Rapid molecular TB diagnosis: evidence, policy making and global implementation of Xpert MTB/RIF
Open accessThe DOI matches its Crossref record; 136 of the 137 references it cites were found in a registry or an index.
Abstract
If tuberculosis (TB) is to be eliminated as a global health problem in the foreseeable future, improved detection of patients, earlier diagnosis and timely identification of rifampicin resistance will be critical. New diagnostics released in recent years have improved this perspective but they require investments in laboratory infrastructure, biosafety and staff specialisation beyond the means of many resource-constrained settings where most patients live. Xpert MTB/RIF, a new assay employing automated nucleic acid amplification to detect Mycobacterium tuberculosis , as well as mutations that confer rifampicin resistance, holds the promise to largely overcome these operational challenges. In this article we position Xpert MTB/RIF in today’s TB diagnostic landscape and describe its additional potential as an adjunct to surveillance and surveys, taking into account considerations of pricing and ethics. In what could serve as a model for the future formulation of new policy on diagnostics, we trace the unique process by which the World Health Organization consulted international expertise and systematically assessed published evidence and freshly emerging experience from the field ahead of its endorsement of the Xpert MTB/RIF technology in 2010, summarise subsequent research findings and guidance on who to test and how, and provide perspectives on scaling up the new technology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![FIGURE 2 The step-by-step Xpert MTB/RIF assay process. SR: sterilising reagent. Reproduced from [6] with permission from the publisher.](https://figures.cochat.ai/paper-figures/98f7479eb2a54ba68e155f0517fcac34/rapid-molecular-tb-diagnosis-evidence-policy-making-and-global-implementation-of-figure-2.png)

![FIGURE 4 Global uptake of Xpert MTB/RIF up to June 30, 2012. As of June 30, 2012, a total of 749 GeneXpert instruments (comprising 3602 modules) and 1107330 Xpert MTB/ RIF cartridges had been procured in the public sector in 67 of the 145 countries eligible for concessional pricing. Reproduced from [6] with permission from the publisher.](https://figures.cochat.ai/paper-figures/4789cae0ecc24836a2aa7c4f09135c32/rapid-molecular-tb-diagnosis-evidence-policy-making-and-global-implementation-of-figure-4.png)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rapid Molecular Detection of Tuberculosis and Rifampin Resistance
Boehme, C. C., Nabeta, P., Hillemann, D., Nicol, M. P., Shenai, S., Krapp, F., Allen, J., Tahirli, R., Blakemore, R., Rustomjee, R., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907847 · Cited by 2,309
Grading quality of evidence and strength of recommendations for diagnostic tests and strategies
Schünemann, H. J., Oxman, A. D., Brozek, J., Glasziou, P., Jaeschke, R., Vist, G. E., Williams, J. W., Kunz, R., Craig, J., Montori, V. M., et al. (2008) · BMJ · doi:10.1136/bmj.39500.677199.ae · Cited by 1,782
Quantifying the burden of disease: the technical basis for disability-adjusted life years.
Murray, C. J. L. (1994) · Europe PMC (PubMed Central) · Cited by 1,581
WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update
Falzon, D., Jaramillo, E., Schünemann, H. J., Arentz, M., Bauer, M., Bayona, J., Blanc, L., Caminero, J. A., Daley, C. L., Duncombe, C., et al. (2011) · European Respiratory Journal · doi:10.1183/09031936.00073611 · Cited by 1,100
Self-citationSelective Primary Health Care: An Interim Strategy for Disease Control in Developing Countries
Walsh, J. A., & Warren, K. S. (1979) · New England Journal of Medicine · doi:10.1056/nejm197911013011804 · Cited by 1,034
Boehme, C. C., Nicol, M. P., Nabeta, P., Michael, J. S., Gotuzzo, E., Tahirli, R., Gler, M. T., Blakemore, R., Worodria, W., Gray, C., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60438-8 · Cited by 1,013
Infections and inequalities: the modern plagues
(2001) · Choice Reviews Online · doi:10.5860/choice.38-3356 · Cited by 958
Helb, D., Jones, M., Story, E., Boehme, C., Wallace, E., Ho, K., Kop, J., Owens, M. R., Rodgers, R., Banada, P., et al. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.01463-09 · Cited by 914
Fox, W., Ellard, G. A., & Mitchison, D. A. (1999) · PubMed · Cited by 797
Tuberculosis in New York City — Turning the Tide
Frieden, T. R., Fujiwara, P. I., Washko, R. M., & Hamburg, M. A. (1995) · New England Journal of Medicine · doi:10.1056/nejm199507273330406 · Cited by 640
Totally Drug-Resistant Tuberculosis in India
Udwadia, Z. F., Amale, R. A., Ajbani, K. K., & Rodrigues, C. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cir889 · Cited by 527
Community-Based Therapy for Multidrug-Resistant Tuberculosis in Lima, Peru
Mitnick, C., Bayona, J., Palacios, E., Shin, S., Furin, J., Alcántara, F., Sánchez, E., Sarria, M., Becerra, M., Fawzi, M. C. S., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022928 · Cited by 489
Lawn, S. D., & Nicol, M. P. (2011) · Future Microbiology · doi:10.2217/fmb.11.84 · Cited by 486
Evaluation of the analytical performance of the Xpert MTB/RIF assay
Blakemore, R., Story, E., Helb, D., Kop, J., Banada, P., Owens, M. R., Chakravorty, S., Jones, M., & Alland, D. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.00128-10 · Cited by 485
Molecular beacon sequence analysis for detecting drug resistance in Mycobacterium tuberculosis
Piatek, A. S., Tyagi, S., Pol, A. C., Telenti, A., Miller, L. P., Kramer, F. R., & Alland, D. (1998) · Nature Biotechnology · doi:10.1038/nbt0498-359 · Cited by 419
Rapid Molecular Detection of Extrapulmonary Tuberculosis by the Automated GeneXpert MTB/RIF System
Hillemann, D., Rüsch-Gerdes, S., Boehme, C., & Richter, E. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.02268-10 · Cited by 413
Getahun, H., Kittikraisak, W., Heilig, C. M., Corbett, E. L., Ayles, H., Cain, K. P., Grant, A. D., Churchyard, G. J., Kimerling, M., Shah, S., et al. (2011) · PLoS Medicine · doi:10.1371/journal.pmed.1000391 · Cited by 404
Bifani, P. J. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03530300036037 · Cited by 381
Zeka, A. N., Tasbakan, S., & Cavusoglu, C. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.05434-11 · Cited by 362
Xpert MTB/RIF: a New Pillar in Diagnosis of Extrapulmonary Tuberculosis?
Vadwai, V., Boehme, C., Nabeta, P., Shetty, A., Alland, D., & Rodrigues, C. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.02319-10 · Cited by 357
Scaling up interventions to achieve global tuberculosis control: progress and new developments
Raviglione, M., Marais, B., Floyd, K., Lönnroth, K., Getahun, H., Migliori, G. B., Harries, A. D., Nunn, P., Lienhardt, C., Graham, S., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60727-2 · Cited by 340
Self-citationNicol, M. P., Workman, L., Isaacs, W., Munro, J., Black, F., Eley, B., Boehme, C. C., Zemanay, W., & Zar, H. J. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70167-0 · Cited by 338
Clinical validation of Xpert MTB/RIF for the diagnosis of extrapulmonary tuberculosis
Tortoli, E., Russo, C., Piersimoni, C., Mazzola, E., Dal Monte, P., Pascarella, M., Borroni, E., Mondo, A., Piana, F., Scarparo, C., et al. (2012) · European Respiratory Journal · doi:10.1183/09031936.00176311 · Cited by 322
Self-citationVassall, A., van Kampen, S., Sohn, H., Michael, J. S., John, K. R., den Boon, S., Davis, J. L., Whitelaw, A., Nicol, M. P., Gler, M. T., et al. (2011) · PLoS Medicine · doi:10.1371/journal.pmed.1001120 · Cited by 313
Extensively drug-resistant tuberculosis
Jassal, M., & Bishai, W. R. (2009) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(08)70260-3 · Cited by 312
Theron, G., Peter, J., van Zyl-Smit, R., Mishra, H., Streicher, E., Murray, S., Dawson, R., Whitelaw, A., Hoelscher, M., Sharma, S., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201101-0056oc · Cited by 311
Social scientists and the new tuberculosis
Farmer, P. (1997) · Social Science & Medicine · doi:10.1016/s0277-9536(96)00143-8 · Cited by 305
Surveillance of anti-tuberculosis drug resistance in the world: an updated analysis, 2007–2010
Zignol, M., van Gemert, W., Falzon, D., Sismanidis, C., Glaziou, P., Floyd, K., & Raviglione, M. (2012) · Bulletin of the World Health Organization · doi:10.2471/blt.11.092585 · Cited by 295
Self-citationGlobal tuberculosis control report.
Thakur, M. (2001) · PubMed · Cited by 292
Leimane, V., Riekstina, V., Holtz, T. H., Zarovska, E., Skripconoka, V., Thorpe, L. E., Laserson, K. F., & Wells, C. D. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17786-1 · Cited by 279
Lawn, S. D., Brooks, S. V., Kranzer, K., Nicol, M. P., Whitelaw, A., Vogt, M., Bekker, L.-G., & Wood, R. (2011) · PLoS Medicine · doi:10.1371/journal.pmed.1001067 · Cited by 278
Chang, K., Lu, W., Wang, J., Zhang, K., Jia, S., Li, F., Deng, S., & Chen, M. (2012) · Journal of Infection · doi:10.1016/j.jinf.2012.02.012 · Cited by 267
Exogenous Reinfection with Tuberculosis in a Shelter for the Homeless
Nardell, E., McInnis, B., Thomas, B., & Weidhaas, S. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612183152502 · Cited by 265
Streptomycin Resistance in Pulmonary Tuberculosis
Crofton, J., & Mitchison, D. A. (1948) · BMJ · doi:10.1136/bmj.2.4588.1009 · Cited by 261
Marlowe, E. M., Novak-Weekley, S. M., Cumpio, J., Sharp, S. E., Momeny, M. A., Babst, A., Carlson, J. S., Kawamura, M., & Pandori, M. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.02214-10 · Cited by 253
The Treatment of Multidrug-Resistant Tuberculosis in Turkey
Tahaoğlu, K., Törün, T., Sevim, T., Ataç, G., Kir, A., Karasulu, L., Özmen, İ., & Kapaklı, N. (2001) · New England Journal of Medicine · doi:10.1056/nejm200107193450303 · Cited by 248
Piatek, A. S., Telenti, A., Murray, M. R., El-Hajj, H., Jacobs, W. R., Kramer, F. R., & Alland, D. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.1.103-110.2000 · Cited by 218
Tuberculosis Diagnosis — Time for a Game Change
Small, P. M., & Pai, M. (2010) · New England Journal of Medicine · doi:10.1056/nejme1008496 · Cited by 196
Selective primary health care: A critical review of methods and results
Unger, J., & Killingsworth, J. R. (1986) · Social Science & Medicine · doi:10.1016/0277-9536(86)90200-5 · Cited by 187
Mycobacterium tuberculosis Strains with Highly Discordant Rifampin Susceptibility Test Results
Van Deun, A., Barrera, L., Bastian, I., Fattorini, L., Hoffmann, H., Kam, K. M., Rigouts, L., Rüsch-Gerdes, S., & Wright, A. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.01209-09 · Cited by 186
El-Hajj, H. H., Marras, S. A. E., Tyagi, S., Kramer, F. R., & Alland, D. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.11.4131-4137.2001 · Cited by 180
Armand, S., Vanhuls, P., Delcroix, G., Courcol, R., & Lemaître, N. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.02157-10 · Cited by 179
TREATMENT OF TUBERCULOSIS WITH STREPTOMYCIN: A Summary of Observations on One Hundred Cases
Hinshaw, H. C. (1946) · JAMA · doi:10.1001/jama.1946.02870480024007 · Cited by 178
GeneXpert—A Game-Changer for Tuberculosis Control?
Evans, C. A. (2011) · PLoS Medicine · doi:10.1371/journal.pmed.1001064 · Cited by 172
Scott, L. E., McCarthy, K., Gous, N., Nduna, M., Van Rie, A., Sanne, I., Venter, W. F., Duse, A., & Stevens, W. (2011) · PLoS Medicine · doi:10.1371/journal.pmed.1001061 · Cited by 171
Suárez, Floyd, Portocarrero, & Alarcon (2002) · The Lancet · Cited by 166
Rapid Molecular Diagnosis of Pulmonary Tuberculosis in Children Using Nasopharyngeal Specimens
Zar, H. J., Workman, L., Isaacs, W., Munro, J., Black, F., Eley, B., Allen, V., Boehme, C. C., Zemanay, W., & Nicol, M. P. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis598 · Cited by 165
Moure, R., Muñoz, L., Torres, M., Santin, M., Martín, R., & Alcaide, F. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.01831-10 · Cited by 165
Rachow, A., Zumla, A., Heinrich, N., Rojas-Ponce, G., Mtafya, B., Reither, K., Ntinginya, E. N., O'Grady, J., Huggett, J., Dheda, K., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020458 · Cited by 160
Rie, A. V., Page-Shipp, L., Scott, L., Sanne, I., & Stevens, W. (2010) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.10.67 · Cited by 159
The Impact and Cost of Scaling up GeneXpert MTB/RIF in South Africa
Meyer-Rath, G., Schnippel, K., Long, L., MacLeod, W., Sanne, I., Stevens, W., Pillay, S., Pillay, Y., & Rosen, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036966 · Cited by 158
Ioannidis, P., Papaventsis, D., Karabela, S., Nikolaou, S., Panagi, M., Raftopoulou, E., Konstantinidou, E., Marinou, I., & Kanavaki, S. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.00718-11 · Cited by 153
Banada, P. P., Sivasubramani, S. K., Blakemore, R., Boehme, C., Perkins, M. D., Fennelly, K., & Alland, D. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.01053-10 · Cited by 149
Rachow, A., Clowes, P., Saathoff, E., Mtafya, B., Michael, E., Ntinginya, E. N., Kowour, D., Rojas-Ponce, G., Kroidl, A., Maboko, L., et al. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis190 · Cited by 147
Comparison of Two Molecular Methods for Rapid Diagnosis of Extrapulmonary Tuberculosis
Causse, M., Ruiz, P., Gutiérrez-Aroca, J. B., & Casal, M. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.00491-11 · Cited by 145
Hsu, J., Brożek, J. L., Terracciano, L., Kreis, J., Compalati, E., Stein, A. T., Fiocchi, A., & Schünemann, H. J. (2011) · Implementation Science · doi:10.1186/1748-5908-6-62 · Cited by 141
Responding to Market Failures in Tuberculosis Control
Gupta, R., Kim, J. Y., Espinal, M. A., Caudron, J.-M., Pecoul, B., Farmer, P. E., & Raviglione, M. C. (2001) · Science · doi:10.1126/science.1061861 · Cited by 136
Self-citationKimerling, M. E., Kluge, H. H. P., Vezhnina, N., Iacovazzi, T., Demeulenaere, T., Portaels, F., & Matthys, F. (1999) · PubMed · Cited by 133
Diagnosis of extrapulmonary tuberculosis using the Xpert®MTB/RIF assay
Lawn, S. D., & Zumla, A. I. (2012) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.12.43 · Cited by 127
Xpert® MTB/RIF for national tuberculosis programmes in low-income countries: when, where and how?
Trébucq, A., Enarson, D. A., Chiang, C. Y., Van Deun, A., Harries, A. D., Boillot, F., Detjen, A., Fujiwara, P. I., Graham, S. M., Monedero, I., et al. (2011) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.11.0392 · Cited by 126
Comparison of Quantitative Techniques including Xpert MTB/RIF to Evaluate Mycobacterial Burden
van Zyl-Smit, R. N., Binder, A. B., Meldau, R., Mishra, H. K., Semple, P. L., Theron, G., Peter, J., Whitelaw, A. C., Sharma, S. K., Warren, R. M., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028815 · Cited by 126
Xpert MTB/RIF Assay for Diagnosis of Pleural Tuberculosis
Friedrich, S. O., von Groote-Bidlingmaier, F., & Diacon, A. H. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.05454-11 · Cited by 126
Selective primary health care: Old wine in new bottles
Gish, O. (1982) · Social Science & Medicine · doi:10.1016/0277-9536(82)90177-0 · Cited by 124
TREATMENT OF PULMONARY TUBERCULOSIS WITH HYDRAZIDE DERIVATIVES OF ISONICOTINIC ACID
Selikoff, I. J. (1952) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1952.03680100015006 · Cited by 124
Ligthelm, L. J., Nicol, M. P., Hoek, K. G. P., Jacobson, R., van Helden, P. D., Marais, B. J., Warren, R. M., & Wright, C. A. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.01310-11 · Cited by 123
A multisite assessment of the quantitative capabilities of the Xpert MTB/RIF assay
Blakemore, R., Nabeta, P., Davidow, A. L., Vadwai, V., Tahirli, R., Munsamy, V., Nicol, M., Jones, M., Persing, D. H., Hillemann, D., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201103-0536oc · Cited by 118
Barnard, M., van Pittius, N. C. G., van Helden, P. D., Bosman, M. E., Coetzee, G. J., & Warren, R. M. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.01958-12 · Cited by 116
Captain of death: the story of tuberculosis
(1998) · Choice Reviews Online · doi:10.5860/choice.35-5685 · Cited by 113
Pantoja, A., Fitzpatrick, C., Vassall, A., Weyer, K., & Floyd, K. (2013) · European Respiratory Journal · doi:10.1183/09031936.00147912 · Cited by 105
Self-citationAlvarez-Uria, G., Azcona, J. M., Midde, M., Naik, P. K., Reddy, S., & Reddy, R. (2012) · Tuberculosis Research and Treatment · doi:10.1155/2012/932862 · Cited by 104
Fox, W., Wiener, A., Mitchison, D. A., Selkon, J. B., & Sutherland, I. (1957) · Tubercle · doi:10.1016/s0041-3879(57)80001-4 · Cited by 100
Moure, R., Martín, R., & Alcaide, F. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.06467-11 · Cited by 90
Peter, J. G., Theron, G., Muchinga, T. E., Govender, U., & Dheda, K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039966 · Cited by 89
Extensively Drug‐Resistant Tuberculosis: “There must be some kind of way out of here”
Cegielski, J. P. (2010) · Clinical Infectious Diseases · doi:10.1086/651491 · Cited by 85
Andrews, J. R., Lawn, S. D., Rusu, C., Wood, R., Noubary, F., Bender, M. A., Horsburgh, C. R., Losina, E., Freedberg, K. A., & Walensky, R. P. (2012) · AIDS · doi:10.1097/qad.0b013e3283522d47 · Cited by 83
Williamson, D. A., Basu, I., Bower, J. E., Freeman, J. T., Henderson, G., & Roberts, S. (2012) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2012.06.013 · Cited by 81
Malbruny, B., Le Marrec, G., Courageux, K., Leclercq, R., & Cattoir, V. (2011) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.10.0497 · Cited by 79
Miller, M. B., Popowitch, E. B., Backlund, M. G., & Ager, E. P. C. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.05212-11 · Cited by 77
Selective primary health care: Is efficient sufficient?
Berman, P. (1982) · Social Science & Medicine · doi:10.1016/0277-9536(82)90178-2 · Cited by 74
O'Grady, J., Bates, M., Chilukutu, L., Mzyece, J., Cheelo, B., Chilufya, M., Mukonda, L., Mumba, M., Tembo, J., Chomba, M., et al. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis631 · Cited by 74
Lawn, S. D., Kerkhoff, A. D., Vogt, M., Ghebrekristos, Y. T., Whitelaw, A. C., & Wood, R. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cir1039 · Cited by 73
Van Rie, A., Mellet, K., John, M.-A., Scott, L., Page-Shipp, L., Dansey, H., Victor, T., & Warren, R. (2012) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.11.0395 · Cited by 73
Point-of-care diagnostics for HIV and tuberculosis: landscape, pipeline, and unmet needs.
Pai, N. P., & Pai, M. (2012) · PubMed · Cited by 70
Beyond the World Bank agenda : an institutional approach to development
Stein, H. (2008) · doi:10.7208/9780226771656 · Cited by 70
Migliori, G. B., Espinal, M., Danilova, I. D., Пунга, В. В., Grzemska, M., & Raviglione, M. C. (2002) · PubMed · Cited by 70
Self-citationEarly tuberculosis treatment monitoring by Xpert® MTB/RIF: Figure 1–
Miotto, P., Bigoni, S., Migliori, G. B., Matteelli, A., & Cirillo, D. M. (2012) · European Respiratory Journal · doi:10.1183/09031936.00124711 · Cited by 68
Self-citationPerformance Characteristics of the Cepheid Xpert MTB/RIF Test in a Tuberculosis Prevalence Survey
Dorman, S. E., Chihota, V. N., Lewis, J. J., Shah, M., Clark, D., Grant, A. D., Churchyard, G. J., & Fielding, K. L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043307 · Cited by 65
Theron, G., Pooran, A., Peter, J., van Zyl-Smit, R., Kumar Mishra, H., Meldau, R., Calligaro, G., Allwood, B., Sharma, S. K., Dawson, R., et al. (2012) · European Respiratory Journal · doi:10.1183/09031936.00145511 · Cited by 64
Smith, S. E., Kurbatova, E. V., Cavanaugh, J. S., & Cegielski, J. P. (2011) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.11.0445 · Cited by 63
Is Scale-Up Worth It? Challenges in Economic Analysis of Diagnostic Tests for Tuberculosis
Dowdy, D. W., Cattamanchi, A., Steingart, K. R., & Pai, M. (2011) · PLoS Medicine · doi:10.1371/journal.pmed.1001063 · Cited by 62
Kim, J. Y., Mukherjee, J. S., Rich, M., Mate, K. S., Bayona, J. N., & Becerra, M. C. (2003) · Tuberculosis · doi:10.1016/s1472-9792(02)00078-1 · Cited by 59
Rifampin in the Treatment of Drug-ResistantMycobacterium tuberculosisInfections
Vall-Spinosa, A., Lester, W. T., Moulding, T., Davidson, P. T., & McClatchy, J. K. (1970) · New England Journal of Medicine · doi:10.1056/nejm197009172831202 · Cited by 58
Picking Up the Pace — Scale-Up of MDR Tuberculosis Treatment Programs
Keshavjee, S. A., & Farmer, P. E. (2010) · New England Journal of Medicine · doi:10.1056/nejmp1010023 · Cited by 57
Teo, J., Jureen, R., Chiang, D., Chan, D., & Lin, R. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.00211-11 · Cited by 56
The Beginning of the End of AIDS?
Havlir, D. V., & Beyrer, C. (2012) · New England Journal of Medicine · doi:10.1056/nejmp1207138 · Cited by 55
Which New Diagnostics for Tuberculosis, and When?
Cobelens, F., van den Hof, S., Pai, M., Squire, S. B., Ramsay, A., & Kimerling, M. E. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis188 · Cited by 55
Schnippel, K., Meyer‐Rath, G., Long, L., MacLeod, W., Sanne, I., Stevens, W. S., & Rosen, S. (2012) · Tropical Medicine & International Health · doi:10.1111/j.1365-3156.2012.03028.x · Cited by 54
Development of Drug Resistance to Rifampicin
Manten, A., & Wijngaarden, L. J. V. (2009) · Chemotherapy · doi:10.1159/000220615 · Cited by 53
Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test
Bodmer, T., & Ströhle, A. (2012) · Journal of Visualized Experiments · doi:10.3791/3547 · Cited by 51
Carriquiry, G., Otero, L., González-Lagos, E., Zamudio, C., Sánchez, E., Nabeta, P., Campos, M. A. L., Echevarria, J. I., Seas, C., & Gotuzzo, E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044626 · Cited by 51
Lawn, S. D., Kerkhoff, A. D., Vogt, M., & Wood, R. (2012) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e318258c6af · Cited by 51
Mechanisms Used for Genomic Proliferation by Thermophilic Group II Introns
Mohr, G., Ghanem, E., & Lambowitz, A. M. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000391 · Cited by 49
Abimbola, T. O., Marston, B. J., Date, A. A., Blandford, J. M., Sangrujee, N., & Wiktor, S. Z. (2012) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e318246538f · Cited by 44
Han, L., Sloutsky, A., Canales, R., Naroditskaya, V., Shin, S. S., Seung, K. J., Timperi, R., & Becerra, M. C. (2005) · PubMed · Cited by 43
The multidrug-resistant tuberculosis challenge to public health efforts to control tuberculosis.
Villarino, M. E., Geiter, L. J., & Simone, P. M. (1992) · Europe PMC (PubMed Central) · Cited by 43
Primary Drug-Resistant Tuberculosis
Steiner, M., Chaves, A. D., Lyons, H. A., Steiner, P., & Portugaleza, C. (1970) · New England Journal of Medicine · doi:10.1056/nejm197012172832501 · Cited by 42
Theron, G., Pinto, L., Peter, J., Mishra, H. K., Mishra, H. K., van Zyl-Smit, R. N., Sharma, S. K., & Dheda, K. U. J. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir824 · Cited by 42
Lawn, S. D., Kerkhoff, A. D., & Wood, R. (2012) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.12.0131 · Cited by 41
Scott, L. E., Gous, N. M., Cunningham, B., Kana, B. D., Perovic, O., Erasmus, L., Coetzee, G. J., KOORNHOF, H. J., & Stevens, W. S. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.05167-11 · Cited by 35
Bowles, E., Freyee, B., van Ingen, J., Mulder, B., Boeree, M. J., & van Soolingen, D. (2011) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.10.0574 · Cited by 33
Kirwan, D. E., Cárdenas, M. K., & Gilman, R. H. (2012) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2012.12-0107 · Cited by 31
Hanif, S. N. M., Eldeen, H. S., Ahmad, S., & Mokaddas, E. (2011) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.11.0394 · Cited by 29
Ntinginya, E. N., Squire, S. B., Millington, K. A., Mtafya, B., Saathoff, E., Heinrich, N., Rojas-Ponce, G., Kowuor, D. O., Maboko, L., Reither, K., et al. (2012) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.12.0127 · Cited by 29
Taylor, N., Gaur, R. L., Baron, E. J., & Banaei, N. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.01012-12 · Cited by 28
Vásquez-Campos, L., Asencios-Solís, L., Hurtado, E. L., Quispe-Torres, N., Salazar‐Lindo, E., Bayona, J. N., & Mc, B. (2004) · PubMed · Cited by 28
Turnbull, E., Kancheya, N. G., Harris, J. B., Topp, S. M., Henostroza, G., & Reid, S. E. (2011) · Journal of Pregnancy · doi:10.1155/2012/565049 · Cited by 27
Zignol, M., van Gemert, W., Falzon, D., Jaramillo, E., Blanc, L., & Raviglione, M. C. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir081 · Cited by 25
Self-citationCastro, K. G., & LoBue, P. A. (2011) · Emerging infectious diseases · doi:10.3201/eid1703.110031 · Cited by 24
Multidrug-resistant tuberculosis today
Matteelli, A., Centis, R., D’Ambrosio, L., & Migliori, G. B. (2012) · Bulletin of the World Health Organization · doi:10.2471/blt.11.097360 · Cited by 23
Self-citationRapid molecular detection of pulmonary tuberculosis in HIV-infected patients in Santiago, Chile
Balcells, M. E., García, P., Leonardo Chanqueo, C., Bahamondes, L. G., Lasso, M., Gallardo, A. M. R., & Cifuentes, L. I. (2012) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.12.0156 · Cited by 21
Time to put boots on the ground: making universal access to MDR-TB treatment a reality.
Keshavjee, S. A., & Farmer, P. E. (2010) · PubMed · Cited by 18
Kim, S. Y., Kim, H., Kim, S. Y., Ra, E. K., Joo, S.-I., Shin, S., Seong, M., Yoo, C.-G., Kim, E.-C., & Park, S. S. (2012) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.11.0602 · Cited by 17
The Rise of Tuberculosis in America before 1820
Holmberg, S. D. (1990) · American Review of Respiratory Disease · doi:10.1164/ajrccm/142.5.1228 · Cited by 16
Promising directions in the diagnosis of childhood tuberculosis
Whittaker, E., & Zar, H. J. (2012) · Expert Review of Respiratory Medicine · doi:10.1586/ers.12.36 · Cited by 15
Xpert MTB/RIF test for tuberculosis
Theron, G., Peter, J., & Dheda, K. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61242-7 · Cited by 14
Rifampin — A Major New Chemotherapeutic Agent for the Treatment of Tuberculosis
Daniel, T. M. (1969) · New England Journal of Medicine · doi:10.1056/nejm196903132801112 · Cited by 12
Implementation of a national anti-tuberculosis drug resistance survey in Tanzania
Chonde, T. M., Doulla, B. E., van Leth, F., Mfinanga, S., Range, N. S., Lwilla, F., Mfaume, S. M., Deun, A. V., Matteo Zignol, E., Cobelens, F. G. J., et al. (2008) · BMC Public Health · doi:10.1186/1471-2458-8-427 · Cited by 12
Singh, J. A., & Bhan, A. (2011) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.11.0728 · Cited by 8
Should Xpert® MTB/RIF be rolled out in low-income countries? [Correspondence]
Peters, D. H., Theron, G., Peter, J., & Dheda, K. U. J. (2012) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.12.0034 · Cited by 7
Streptomycin in the Treatment of Extrapulmonary Tuberculosis
Jellinek, K. (1949) · New England Journal of Medicine · doi:10.1056/nejm194904282401703 · Cited by 7
In reply to ‘Should Xpert® MTB/RIF be rolled out in low-income countries?’ [Correspondence]
Trébucq, A., Harries, A. D., & Rieder, H. L. (2012) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.12.0034-2 · Cited by 6
Xpert MTB/RIF test for tuberculosis
Ferrara, G., O’Grady, J., Zumla, A. I., & Maeurer, M. J. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61244-0 · Cited by 5
Characteristics of Xpert MTB/RIF-Negative Patients With Pulmonary Tuberculosis
Theron, G., Peter, J., & Dheda, K. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis465 · Cited by 5
Trébucq, A., & Harries, A. D. (2012) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.12.0131-2 · Cited by 4
Xpert MTB/RIF test for tuberculosis – Authors' reply
Perkins, M. D., Alland, D., Nicol, M. P., Nabeta, P., & Boehme, C. C. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61245-2 · Cited by 3
Transforming TB Diagnosis: Can Patients and Control Programs Afford to Wait?
Talbot, E. A., Pape, J. W., Sundaram, L., Boehme, C. C., & Perkins, M. D. (2012) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2012.12-0247 · Cited by 2
Research works printed but not linked: 1
- 10.1016/S0140-6736(11)61242-7 · DOI
Cited by
Advances in the development of new tuberculosis drugs and treatment regimens
Zumla, A., Nahid, P., & Cole, S. T. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4001 · Cited by 893
Walker, T. M., Kohl, T. A., Omar, S. V., Hedge, J., Del Ojo Elias, C., Bradley, P., Iqbal, Z., Feuerriegel, S., Niehaus, K. E., Wilson, D. J., et al. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00062-6 · Cited by 638
Denkinger, C. M., Schumacher, S. G., Boehme, C. C., Dendukuri, N., Pai, M., & Steingart, K. R. (2014) · European Respiratory Journal · doi:10.1183/09031936.00007814 · Cited by 527
Point-of-Care Diagnostics: Recent Developments in a Connected Age
Nayak, S., Blumenfeld, N. R., Laksanasopin, T., & Sia, S. K. (2017) · Analytical Chemistry · doi:10.1021/acs.analchem.6b04630 · Cited by 508
New antituberculosis drugs, regimens, and adjunct therapies: needs, advances, and future prospects
Zumla, A. I., Gillespie, S. H., Hoelscher, M., Philips, P. P. J., Cole, S. T., Abubakar, I., McHugh, T. D., Schito, M., Maeurer, M., & Nunn, A. J. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70328-1 · Cited by 342
Metadata
- Authors
- Weyer, K., Mirzayev, F., Migliori, G. B., Van Gemert, W., D'Ambrosio, L., Zignol, M., Floyd, K., Centis, R., Cirillo, D. M., Tortoli, E., Gilpin, C., de Dieu Iragena, J., Falzon, D., & Raviglione, M.
- Affiliations
- World Health Organization (CH)
- Fondazione Salvatore Maugeri (IT)
- IRCCS San Raffaele Roma (IT)
- ORCID
- Venue
- European Respiratory Journal
- Publisher
- European Respiratory Society (ERS)
- Published
- 2012-11-22
- Volume
- 42
- Issue
- 1
- Pages
- 252-271
- ISSN
- 0903-1936 (ISSN-L)
- 1399-3003
- OpenAlex
- W2132406189
- Cited by
- 256
- References
- 137
- Citations by year
- 2026: 3 · 2025: 7 · 2024: 14 · 2023: 6 · 2022: 5 · 2021: 16 · 2020: 10 · 2019: 21 · 2018: 17 · 2017: 25 · 2016: 28 · 2015: 33 · 2014: 40 · 2013: 30
- FWCI
- 4.09
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- European Respiratory Journal (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
- Health Sciences › Medicine › Epidemiology › Mycobacterium research and diagnosis
- Keywords
- Xpert MTB/RIF, tuberculosis diagnosis, rifampicin resistance, Mycobacterium tuberculosis, tuberculosis elimination, resource-limited settings, tuberculosis surveillance, rapid molecular diagnostics
- MeSH terms
- Cost-Benefit Analysis, Drug Resistance, Health Policy, Humans, Mycobacterium tuberculosis, Predictive Value of Tests, Sputum, Tuberculosis, Pulmonary, World Health Organization, Reproducibility of Results, Prevalence, Polymerase Chain Reaction, Tuberculosis, Multidrug-Resistant, Nucleic Acid Amplification Techniques, Molecular Diagnostic Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.